Abiopharma

🔍 KOZIN MARC D (Director)

Company: UFP TECHNOLOGIES INC (UFPT)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 3,650 shares of Common Stock, $.01 Par Value at $303.97 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 24,462.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,350 shares of Common Stock, $.01 Par Value at $305.07 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,112.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $303.58 to $304.49, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• F2: The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $304.64 to $305.41, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.